The Complex Regulation of Tanshinone IIA in Rats with Hypertension-Induced Left Ventricular Hypertrophy

作者: Hui Pang , Bing Han , Tao Yu , Zhen Peng

DOI: 10.1371/JOURNAL.PONE.0092216

关键词:

摘要: Tanshinone IIA has definite protective effects on various cardiovascular diseases. However, in hypertension-induced left ventricular hypertrophy (H-LVH), the signaling pathways of tanshinone inhibition remodeling and cardiac dysfunction remain unclear. Two-kidney, one-clip induced hypertensive rats (n = 32) were randomized to receive (5, 10, 15 mg/kg per day) or 5% glucose injection (GS). Sham-operated (n = 8) received 5%GS as control. Cardiac function dimensions assessed by using an echocardiography system. Histological determination fibrosis apoptosis was performed hematoxylin eosin, Masson’s trichrome TUNEL staining. Matrix metalloproteinase 2 (MMP2) tissue inhibitor matrix metalloproteinases type (TIMP2) protein expressions rat myocardial tissues detected immunohistochemistry. Rat cardiomyocytes isolated a Langendorff perfusion method. After 48 h culture, supernatant collected determine potential related proteins impact apoptosis. Compared with sham rats, heart H-LVH (5%GS) group suffered severely from oxidative damage, extracellular (ECM) deposition. In group, treated decreased malondialdehyde (MDA) content increased superoxide dismutase (SOD) activity. inhibited confirmed reduction positive down-regulation Caspase-3 activity Bax/Bcl-2 ratio. Meanwhile, plasma apelin level APJ receptor. suppressed through regulating paracrine factors released TGF-β/Smads pathway conclusion, our vivo study showed that could improve enhancing contractility, inhibiting ECM deposition, limiting damage.

参考文章(58)
Bo Yu, Zhi Zhang, Gui-Zhou Tao, Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chinese Medical Journal. ,vol. 122, pp. 2360- 2365 ,(2009)
Carolyn S.P. Lam, Véronique L. Roger, Richard J. Rodeheffer, Barry A. Borlaug, Felicity T. Enders, Margaret M. Redfield, Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Community-Based Study Journal of the American College of Cardiology. ,vol. 53, pp. 1119- 1126 ,(2009) , 10.1016/J.JACC.2008.11.051
Peter Carmeliet, Mechanisms of angiogenesis and arteriogenesis. Nature Medicine. ,vol. 6, pp. 389- 395 ,(2000) , 10.1038/74651
Yongsheng Li, Yuping Yang, Dan Yu, Qiansheng Liang, The Effect of Tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats Journal of Huazhong University of Science and Technology [Medical Sciences]. ,vol. 29, pp. 476- 480 ,(2009) , 10.1007/S11596-009-0417-5
Kishan Narine, Olivier De Wever, Dillis Van Valckenborgh, Katrien Francois, Marc Bracke, Stefaan Desmet, Marc Mareel, Guido Van Nooten, Growth Factor Modulation of Fibroblast Proliferation, Differentiation, and Invasion: Implications for Tissue Valve Engineering Tissue Engineering. ,vol. 12, pp. 2707- 2716 ,(2006) , 10.1089/TEN.2006.12.2707
Jian Fang, Suo-Wen Xu, Ping Wang, Fu-Tian Tang, Si-Gui Zhou, Jie Gao, Jian-Wen Chen, He-Qing Huang, Pei-Qing Liu, Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension Phytomedicine. ,vol. 18, pp. 58- 64 ,(2010) , 10.1016/J.PHYMED.2010.06.002
Junichi Sadoshima, Redox Regulation of Growth and Death in Cardiac Myocytes Antioxidants & Redox Signaling. ,vol. 8, pp. 1621- 1624 ,(2006) , 10.1089/ARS.2006.8.1621
Celio X.C. Santos, Narayana Anilkumar, Min Zhang, Alison C. Brewer, Ajay M. Shah, Redox signaling in cardiac myocytes. Free Radical Biology and Medicine. ,vol. 50, pp. 777- 793 ,(2011) , 10.1016/J.FREERADBIOMED.2011.01.003
Mark H. Drazner, The Progression of Hypertensive Heart Disease Circulation. ,vol. 123, pp. 327- 334 ,(2011) , 10.1161/CIRCULATIONAHA.108.845792